Dietary fats and diabetes mellitus

is there a good fat?

C. J. Segal-Isaacson, E. Carello, Judith Wylie-Rosett

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

As knowledge of the fatty acid functions has increased, so has the complexity of making dietary fat recommendations to people with type 2 diabetes. Oleic acid seems to offer a slight advantage over linoleic acid in reducing plasma glucose, insulin levels, total cholesterol, low-density lipoproteins (LDLs), and triglycerides, but may also have atherogenic properties through another mechanism. A diet containing a higher proportion of polyunsaturated fatty acids (PUFAs) may require a concomitant increase in antioxidant intake because PUFAs oxidize easily and are then converted to oxidized LDL, which is more atherogenic. In addition to raising total and LDL cholesterol, long chain saturated free fatty acids may interact with plasma glucose to increase insulin secretion. Omega-3 fatty acids decrease triglycerides and reduce the risk of fatal cardiac arrhythmias. Glycemic control does not appear to be adversely affected by omega-3 fatty acids at amounts of up to 3 g/d.

Original languageEnglish (US)
Pages (from-to)161-169
Number of pages9
JournalCurr Diab Rep
Volume1
Issue number2
StatePublished - Oct 2001

Fingerprint

Dietary Fats
Omega-3 Fatty Acids
Unsaturated Fatty Acids
Diabetes Mellitus
Fatty Acids
Fats
Insulin
Glucose
Linoleic Acid
Oleic Acid
Nonesterified Fatty Acids
LDL Cholesterol
Type 2 Diabetes Mellitus
Cardiac Arrhythmias
Triglycerides
Antioxidants
Cholesterol
Diet
oxidized low density lipoprotein
low density lipoprotein triglyceride

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Segal-Isaacson, C. J., Carello, E., & Wylie-Rosett, J. (2001). Dietary fats and diabetes mellitus: is there a good fat? Curr Diab Rep, 1(2), 161-169.

Dietary fats and diabetes mellitus : is there a good fat? / Segal-Isaacson, C. J.; Carello, E.; Wylie-Rosett, Judith.

In: Curr Diab Rep, Vol. 1, No. 2, 10.2001, p. 161-169.

Research output: Contribution to journalArticle

Segal-Isaacson, CJ, Carello, E & Wylie-Rosett, J 2001, 'Dietary fats and diabetes mellitus: is there a good fat?', Curr Diab Rep, vol. 1, no. 2, pp. 161-169.
Segal-Isaacson, C. J. ; Carello, E. ; Wylie-Rosett, Judith. / Dietary fats and diabetes mellitus : is there a good fat?. In: Curr Diab Rep. 2001 ; Vol. 1, No. 2. pp. 161-169.
@article{35fea738e258490dbc0d84b6da4d5efb,
title = "Dietary fats and diabetes mellitus: is there a good fat?",
abstract = "As knowledge of the fatty acid functions has increased, so has the complexity of making dietary fat recommendations to people with type 2 diabetes. Oleic acid seems to offer a slight advantage over linoleic acid in reducing plasma glucose, insulin levels, total cholesterol, low-density lipoproteins (LDLs), and triglycerides, but may also have atherogenic properties through another mechanism. A diet containing a higher proportion of polyunsaturated fatty acids (PUFAs) may require a concomitant increase in antioxidant intake because PUFAs oxidize easily and are then converted to oxidized LDL, which is more atherogenic. In addition to raising total and LDL cholesterol, long chain saturated free fatty acids may interact with plasma glucose to increase insulin secretion. Omega-3 fatty acids decrease triglycerides and reduce the risk of fatal cardiac arrhythmias. Glycemic control does not appear to be adversely affected by omega-3 fatty acids at amounts of up to 3 g/d.",
author = "Segal-Isaacson, {C. J.} and E. Carello and Judith Wylie-Rosett",
year = "2001",
month = "10",
language = "English (US)",
volume = "1",
pages = "161--169",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "2",

}

TY - JOUR

T1 - Dietary fats and diabetes mellitus

T2 - is there a good fat?

AU - Segal-Isaacson, C. J.

AU - Carello, E.

AU - Wylie-Rosett, Judith

PY - 2001/10

Y1 - 2001/10

N2 - As knowledge of the fatty acid functions has increased, so has the complexity of making dietary fat recommendations to people with type 2 diabetes. Oleic acid seems to offer a slight advantage over linoleic acid in reducing plasma glucose, insulin levels, total cholesterol, low-density lipoproteins (LDLs), and triglycerides, but may also have atherogenic properties through another mechanism. A diet containing a higher proportion of polyunsaturated fatty acids (PUFAs) may require a concomitant increase in antioxidant intake because PUFAs oxidize easily and are then converted to oxidized LDL, which is more atherogenic. In addition to raising total and LDL cholesterol, long chain saturated free fatty acids may interact with plasma glucose to increase insulin secretion. Omega-3 fatty acids decrease triglycerides and reduce the risk of fatal cardiac arrhythmias. Glycemic control does not appear to be adversely affected by omega-3 fatty acids at amounts of up to 3 g/d.

AB - As knowledge of the fatty acid functions has increased, so has the complexity of making dietary fat recommendations to people with type 2 diabetes. Oleic acid seems to offer a slight advantage over linoleic acid in reducing plasma glucose, insulin levels, total cholesterol, low-density lipoproteins (LDLs), and triglycerides, but may also have atherogenic properties through another mechanism. A diet containing a higher proportion of polyunsaturated fatty acids (PUFAs) may require a concomitant increase in antioxidant intake because PUFAs oxidize easily and are then converted to oxidized LDL, which is more atherogenic. In addition to raising total and LDL cholesterol, long chain saturated free fatty acids may interact with plasma glucose to increase insulin secretion. Omega-3 fatty acids decrease triglycerides and reduce the risk of fatal cardiac arrhythmias. Glycemic control does not appear to be adversely affected by omega-3 fatty acids at amounts of up to 3 g/d.

UR - http://www.scopus.com/inward/record.url?scp=0035497676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035497676&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 161

EP - 169

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 2

ER -